Last reviewed · How we verify

NCT04325087: COOL

Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation

Status unknown NA Last updated 27 March 2020
What this trial tests

NA trial testing iTBS in Intrusive Thoughts in 120 participants. Status unknown.

Timeline
1 July 2019
Primary endpoint
30 May 2020
30 May 2020

Quick facts

Lead sponsorUniversity Hospital, Bonn
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment120
Start date1 July 2019
Primary completion30 May 2020
Estimated completion30 May 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bonn

Who can join

Adults 18 to 45, any sex, with Intrusive Thoughts or Post Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will focus on the modulation of intrusive memories via functional magnetic resonance imaging (fMRI)-guided repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex (dlPFC) directly after exposure to a traumatic video.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of iTBS

Trials testing the same drug.

Other University Hospital, Bonn trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04325087.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing